Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers

Παρόμοια τεκμήρια

• Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata
  ανά: Mackay-Wiggan, Julian, κ.ά.
  Έκδοση: (2016)
• Rapid Skin Repigmentation on Oral Ruxolitinib in a Patient with Coexistent Vitiligo and Alopecia Areata
  ανά: Harris, John E., κ.ά.
  Έκδοση: (2015)
• An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis
  ανά: Jabbari, A, κ.ά.
  Έκδοση: (2018)
• CXCR3 Blockade Inhibits T-cell Migration into the Skin and Prevents Development of Alopecia Areata
  ανά: Dai, Zhenpeng, κ.ά.
  Έκδοση: (2016)
• Molecular signatures define alopecia areata subtypes and transcriptional biomarkers
  ανά: Jabbari, Ali, κ.ά.
  Έκδοση: (2016)